Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

New Market Research Report: Merrion Pharmaceuticals Plc - Product Pipeline Review - 2012


Print article Print article
2013-01-28 06:58:28 - Fast Market Research recommends "Merrion Pharmaceuticals Plc - Product Pipeline Review - 2012" from Global Markets Direct, now available

Global Market Direct's pharmaceuticals report, "Merrion Pharmaceuticals Plc - Product Pipeline Review - 2012" provides data on the Merrion Pharmaceuticals Plc's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Merrion Pharmaceuticals Plc's corporate website, SEC filings, investor presentations and featured press releases, both from Merrion Pharmaceuticals Plc and industry-specific third party sources, put together by Global Markets Direct's team.


Full Report Details at
- www.fastmr.com/prod/530130_merrion_pharmaceuticals_plc_product_p ..


Scope

* Merrion Pharmaceuticals Plc - Brief Merrion Pharmaceuticals Plc overview including business

description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of Merrion Pharmaceuticals Plc human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Merrion Pharmaceuticals Plc with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Merrion Pharmaceuticals Plc's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.

Reasons to buy

* Evaluate Merrion Pharmaceuticals Plc's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Merrion Pharmaceuticals Plc in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Merrion Pharmaceuticals Plc's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Merrion Pharmaceuticals Plc.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Merrion Pharmaceuticals Plc and identify potential opportunities in those areas.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Merrion Pharmaceuticals Plc Snapshot
Merrion Pharmaceuticals Plc Overview
Key Information
Key Facts
Merrion Pharmaceuticals Plc - Research and Development Overview
Key Therapeutic Areas
Merrion Pharmaceuticals Plc - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Merrion Pharmaceuticals Plc - Pipeline Products Glance
Merrion Pharmaceuticals Plc - Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
Merrion Pharmaceuticals Plc Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Merrion Pharmaceuticals Plc - Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Merrion Pharmaceuticals Plc - Drug Profiles
alendronate sodium
Product Description
Mechanism of Action
R&D Progress
fondaparinux sodium
Product Description
Mechanism of Action
R&D Progress
MER-104
Product Description
Mechanism of Action
R&D Progress
zoledronic acid
Product Description
Mechanism of Action
R&D Progress
Merrion Pharmaceuticals Plc - Pipeline Analysis
Merrion Pharmaceuticals Plc - Pipeline Products by Therapeutic Class
Merrion Pharmaceuticals Plc - Pipeline Products by Route of Administration
Merrion Pharmaceuticals Plc - Pipeline Products By Mechanism of Action
Merrion Pharmaceuticals Plc - Recent Pipeline Updates
Merrion Pharmaceuticals Plc - Dormant Projects
Merrion Pharmaceuticals Plc - Locations And Subsidiaries
Head Office
Merrion Pharmaceuticals Plc, Recent Developments
Merrion Pharmaceuticals Plc- Press Release
Oct 09, 2009: Merrion Pharmaceuticals Plc Announce Presentation At ASCO, 2009 Breast Cancer Symposium, San Francisco.
Jun 11, 2009: Prostate Cancer - Positive Phase IIb Study For Orazol Tablet Form Of Zoledronate IV Infusion By Merrion Pharmaceuticals
Jun 01, 2009: Merrion Drug Orazol Could Be Used To Treat Breast Cancer
May 31, 2009: Merrion Announces Positive Final Results From Phase II Orazol Study
May 15, 2009: Merrion Pharmaceuticals Announces Preliminary Results From Phase II Orazol Study
Mar 10, 2009: Merrion Pharmaceuticals Announces Commencement Of Dosing of Orazol In US Clinical Study
Feb 10, 2009: Merrion Completes Patient Enrolment In Phase IIb Study - Results will Be Announced In Q2 2009
Feb 02, 2009: Merrion Pharmaceuticals Retains Sage Group to Augment Strategic Alliance Efforts
Financial Deals Landscape
Merrion Pharmaceuticals Plc, Deals Summary
Merrion Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deal Details
Asset Transactions
Merrion Pharma Acquires A Pharma Facility For $5 Million
Venture Financing
Merrion Pharma Secures $10 Million In Venture Financing
Merrion Pharma Secures $7.54 Million In Venture Financing
Partnerships
Merrion Pharma Enters Into Research Agreement With Trinity College
Merrion Pharma Enters Into Research Agreement With Hunter-Fleming
Licensing Agreements
Merrion Pharma Enters Into Option Licensing Agreement With Novo Nordisk
Merrion Pharma Enters Into An Option Licensing Agreement With Rebel Pharma

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=530130&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com | BidVertiser